ECM
ALDX icon

ExodusPoint Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History

ExodusPoint Capital Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$283K Buy
167,604
+75,214
+81% +$330K ﹤0.01% 1321
2025
Q4 		$479K Buy
92,390
+77,439
+518% +$398K ﹤0.01% 1195
2025
Q3 		$78K Buy
+14,951
New +$78K ﹤0.01% 1442
2024
Q1 		– Sell
-21,560
Closed -$76K – 1455
2023
Q4 		$76K Sell
21,560
-39,089
-64% -$121K ﹤0.01% 1370
2023
Q3 		$405K Buy
+60,649
New +$450K ﹤0.01% 1311
2023
Q2 		– Sell
-13,800
Closed -$137K – 1817
2023
Q1 		$137K Buy
+13,800
New +$97.5K ﹤0.01% 1608
2022
Q4 		– Sell
-33,685
Closed -$180K – 1602
2022
Q3 		$180K Buy
33,685
+11,190
+50% +$67.1K ﹤0.01% 1666
2022
Q2 		$90K Buy
22,495
+2,364
+12% +$8.13K ﹤0.01% 1752
2022
Q1 		$89K Sell
20,131
-4,900
-20% -$19.5K ﹤0.01% 2013
2021
Q4 		$100K Sell
25,031
-5,463
-18% -$41.7K ﹤0.01% 1950
2021
Q3 		$268K Buy
+30,494
New +$280K ﹤0.01% 1660
2021
Q2 		– Sell
-156,414
Closed -$1.86M – 2288
2021
Q1 		$1.86M Buy
156,414
+16,894
+12% +$195K 0.03% 595
2020
Q4 		$957K Buy
139,520
+128,098
+1,122% +$899K 0.01% 879
2020
Q3 		$85K Sell
11,422
-1,663
-13% -$10.7K ﹤0.01% 1607
2020
Q2 		$55K Buy
+13,085
New +$47.8K ﹤0.01% 1680

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ExodusPoint Capital Management's ALDX Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Aldeyra Therapeutics (ALDX) stake by 81% in Q1 2026, buying an estimated $330K and bringing the position to 167,604 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

ExodusPoint Capital Management first reported a position in ALDX in Q2 2020 and has held it in 15 quarters since. The position peaked at $1.86M in Q1 2021. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • ExodusPoint Capital Management held 167,604 shares of Aldeyra Therapeutics worth $283K as of Q1 2026.
  • ExodusPoint Capital Management bought 75,214 Aldeyra Therapeutics shares in Q1 2026, an estimated $330K.
  • Aldeyra Therapeutics made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1321 holding.
  • ExodusPoint Capital Management first reported a position in Aldeyra Therapeutics in Q2 2020 and has held it in 15 quarters since.
  • ExodusPoint Capital Management's Aldeyra Therapeutics position peaked at $1.86M in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.